Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Related Citations for PubMed (Select 15106171)

1.

Drug treatment for facioscapulohumeral muscular dystrophy.

Rose MR, Tawil R.

Cochrane Database Syst Rev. 2004;(2):CD002276. Review.

PMID:
15106171
2.

Creatine for treating muscle disorders.

Kley RA, Vorgerd M, Tarnopolsky MA.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004760. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD004760.

PMID:
17253521
3.

Strength training and aerobic exercise training for muscle disease.

van der Kooi EL, Lindeman E, Riphagen I.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003907. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD003907.

PMID:
15674918
4.

Strength training and aerobic exercise training for muscle disease.

Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts ACh.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003907. doi: 10.1002/14651858.CD003907.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD003907.

PMID:
20091552
5.

Creatine for treating muscle disorders.

Kley RA, Tarnopolsky MA, Vorgerd M.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD004760. doi: 10.1002/14651858.CD004760.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD004760.

PMID:
21328269
6.

Glucocorticoid corticosteroids for Duchenne muscular dystrophy.

Manzur AY, Kuntzer T, Pike M, Swan A.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003725. doi: 10.1002/14651858.CD003725.pub3. Review.

PMID:
18254031
7.

Glucocorticoid corticosteroids for Duchenne muscular dystrophy.

Manzur AY, Kuntzer T, Pike M, Swan A.

Cochrane Database Syst Rev. 2004;(2):CD003725. Review. Update in: Cochrane Database Syst Rev. 2008;(1):CD003725.

PMID:
15106215
8.

Strength training and aerobic exercise training for muscle disease.

Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC.

Cochrane Database Syst Rev. 2013 Jul 9;7:CD003907. doi: 10.1002/14651858.CD003907.pub4. Review.

PMID:
23835682
9.

Creatine for treating muscle disorders.

Kley RA, Tarnopolsky MA, Vorgerd M.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD004760. doi: 10.1002/14651858.CD004760.pub4. Review.

PMID:
23740606
10.

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.

Kissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R; FSH-DY Group.

Neurology. 2001 Oct 23;57(8):1434-40.

PMID:
11673585
11.

Scapular fixation in muscular dystrophy.

Orrell RW, Copeland S, Rose MR.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003278. doi: 10.1002/14651858.CD003278.pub2. Review.

PMID:
20091543
12.

Drug treatment for spinal muscular atrophy types II and III.

Wadman RI, Bosboom WM, van der Pol WL, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006282. doi: 10.1002/14651858.CD006282.pub4. Review.

PMID:
22513940
13.

Drug treatment for spinal muscular atrophy types II and III.

Wadman RI, Bosboom WM, van den Berg LH, Wokke JH, Iannaccone ST, Vrancken AF.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006282. doi: 10.1002/14651858.CD006282.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006282.

PMID:
22161400
14.

Rehabilitation interventions for foot drop in neuromuscular disease.

Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hoppitt T.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD003908. doi: 10.1002/14651858.CD003908.pub3. Review.

PMID:
19588347
15.

Long acting beta-agonists versus theophylline for maintenance treatment of asthma.

Shah L, Wilson AJ, Gibson PG, Coughlan J.

Cochrane Database Syst Rev. 2003;(3):CD001281. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD001281.

PMID:
12917905
16.

Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.

Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD010179. doi: 10.1002/14651858.CD010179. Review.

PMID:
23235685
17.

Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.

Payan CA, Hogrel JY, Hammouda EH, Lacomblez L, Ollivier G, Doppler V, Eymard B, Attarian S, Pouget J, Desnuelle C, LaforĂȘt P.

Arch Phys Med Rehabil. 2009 Jul;90(7):1094-101. doi: 10.1016/j.apmr.2008.12.027.

PMID:
19577021
18.

Interventions for non-oliguric hyperkalaemia in preterm neonates.

Vemgal P, Ohlsson A.

Cochrane Database Syst Rev. 2012 May 16;5:CD005257. doi: 10.1002/14651858.CD005257.pub3. Review.

PMID:
22592703
19.

Scapular fixation in muscular dystrophy.

Mummery CJ, Copeland SA, Rose MR.

Cochrane Database Syst Rev. 2003;(3):CD003278. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD003278.

PMID:
12917959
20.

Strength training and albuterol in facioscapulohumeral muscular dystrophy.

van der Kooi EL, Vogels OJ, van Asseldonk RJ, Lindeman E, Hendriks JC, Wohlgemuth M, van der Maarel SM, Padberg GW.

Neurology. 2004 Aug 24;63(4):702-8.

PMID:
15326246
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk